Researchers identify new way to disrupt Immune Cells that trigger Allergic Asthma
A team of researchers at the Keck School of Medicine, University of Southern California, have made a significant breakthrough in understanding the mechanisms of allergic asthma and potentially discovered a new treatment approach.
Allergic asthma is a subtype of asthma where the symptoms are triggered by exposure to allergens. The primary cells responsible for driving allergic asthma are Type 2 innate lymphoid cells (ILC2s). These immune cells, residing in the lungs, skin, and other tissues, become hyperactive in the presence of allergens, leading to proinflammatory signals that call additional immune cells into the lungs. This cascade of events results in excessive inflammation and a tightening of the airways, making it difficult for asthma patients to breathe.
ILC2s are crucial driv...